Affordable Microbial CRDMO Options for Preclinical Research
For organizations evaluating a cost-conscious partner to move biologic candidates from early concept into preclinical and IND-enabling studies, Yaohai Bio-Pharma presents a model built specifically around microbial expression systems rather...
